Atlas Trials

A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042

Clinical trial NCT06525649 · COMPLETED

Trial details

NCT number
NCT06525649
Sponsor
NeuroPro Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Photosensitive EpilepsyEpilepsy
Start date
2024-08-21
Primary completion
2025-06-26
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.